Mallinckrodt Pharmaceuticals
MNK
$0.61
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Total assets
Total assets on the balance sheet as of June 2023 : NZ$9.12 Billion
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's total assets are NZ$9.12 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Mallinckrodt Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | NZ$9.47 B | -27.44% |
| 2021-12-31 | NZ$13.05 B | -3.05% |
| 2020-12-31 | NZ$13.46 B | -12.29% |
| 2019-12-31 | NZ$15.35 B | -5.33% |
| 2018-12-31 | NZ$16.21 B | -24.63% |
| 2017-12-31 | NZ$21.51 B | |
| 2016-09-30 | NZ$21.38 B | -17.15% |
| 2015-09-30 | NZ$25.81 B | 55.82% |
| 2014-09-30 | NZ$16.56 B | 285.16% |
| 2013-09-30 | NZ$4.30 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | NZ$321.79 B | 3,426.68% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
 | NZ$70.26 B | 670.06% | 🇮🇱 Israel |
 | NZ$220.01 B | 2,311.25% | 🇺🇸 USA |